(1)
A Randomized Controlled Trial Comparing Vonoprazan and Proton Pump Inhibitors for Symptom Relief and Mucosal Healing in Scleroderma-Associated GERD. JOC 2025, 24 (8s), 542-546. https://doi.org/10.64149/J.Carcinog.24.8s.542-546.